The Omega-3 Fatty Acid Paediatric Depression Trial
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study investigates the therapeutic efficacy and safety of omega-3 fatty acids rich in
eicosapentaenoic acid / docosahexaenoic acid in pediatric depression in a nine months
double-blind multi-centre study in 220 children and adolescents between 8 and 17 years of
age. Inflammatory and bioactive lipid markers as predictors of response are evaluated. The
relationship between omega-3 fatty acids with psychopathology, illness course and cognitive
parameters will be further investigated.